Moderna, Inc. (MRNA) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

12/25

Growth 2 Margin 1 Expansion 4 Platform 2 Financial 3

latest quarter score

Earnings Reports

12
Moderna (MRNA) Q2 2026: R&D Costs Drop 7% as Pipeline Readouts Approach
July 31, 2026
12
Moderna (MRNA) Q4 2025: Cost Cuts Slash OpEx 30%, Setting Stage for 10% Growth Pivot
June 15, 2026
10
Moderna (MRNA) Q1 2026: International Sales Drive 80% Mix, Litigation Charge Clouds Profit Path
May 01, 2026
14
Moderna (MRNA) Q3 2025: $900M Cost Reduction Accelerates Path to 2028 Cash Break-Even
November 06, 2025
9
Moderna (MRNA) Q2 2025: Operating Expenses Cut by $400M as Pipeline Progress Offsets Revenue Shift
August 01, 2025
7
Moderna (MRNA) Q1 2025: R&D Spend to Drop 55% by 2027 as Pipeline Focus Tightens
July 07, 2025

Browse all companies